Publications by authors named "Mohammed Alhejaili"
Article Synopsis
- * A systematic review analyzed six trials with over 3,000 women to evaluate the effectiveness and safety of oral Fezolinetant for treating these VMSs, comparing it to a placebo.
- * Results showed that Fezolinetant significantly reduced the frequency and severity of VMSs without increasing adverse events, especially at a dosage of 45 mg daily, but more research is needed for long-term safety and effectiveness compared to other treatments.
Human norovirus (HuNoV) is one of the leading causes of acute gastroenteritis globally. HuNoV outbreaks have been recently reported during air travels. Contaminated surfaces are known as a critical transmission route at various settings.
View Article and Find Full Text PDF